Join clinicians, laboratory specialists, and researchers for a focused meeting that bridges clinical care, diagnostics, and basic science to advance outcomes for people with Fabry disease.
We’ll spotlight research models—from patient-derived samples to iPSC/organ-on-chip systems, multi-omics, and GLA-knockout animal models—alongside new therapeutic strategies, including next-generation ERT, pharmacological chaperones and substrate-reduction approaches.
Whether you work at the bench or at the bedside, this symposium offers practical insights, emerging data, and opportunities for collaboration—moving discoveries from models to medicine.
